• 제목/요약/키워드: Malignant or aggressive tumor

검색결과 67건 처리시간 0.028초

쇄골 상부에 발생한 악성 Triton 종양 1예 (A Case of Malignant Triton Tumor on Supraclavicular Area)

  • 임상호;박희택;홍기환
    • 대한두경부종양학회지
    • /
    • 제29권2호
    • /
    • pp.54-57
    • /
    • 2013
  • Malignant triton tumor(MTT) is a rare type of malignant peripheral nerve sheath tumor(MPNST) with focal rhabdomyoblastic differentiation. MTT constitutes about 5% of all MPNSTs and described the first case of a MTT in a patient with Von Recklinghausen disease by Masson in 1932. MTT is commonly seen in the head, neck, extremities and trunk. It can occur in sporadic form or over a setting of neurofibromatosis-1(NF-1). The diagnosis can be confirmed based on morphologic grounds supported by an immunostain such as S-100 protein. Desmin, myo-D1 and myogenin are immunostains positive for rhabdomyoblasts. MTT has an aggressive biological behavior so prognosis of this rare and highly malignant tumor is poor and optimal treatment remains unclear. But modern treatment consisted of radical excision and postoperative radiotherapy has improved the prognosis of such cases.

질에 발생한 공격성 혈관점액종 1예 (Case of Aggressive Angiomyxoma of the Vagina)

  • 조향정;김병륜;조해중;홍기연;문형배
    • 동의생리병리학회지
    • /
    • 제22권1호
    • /
    • pp.209-211
    • /
    • 2008
  • Aggressive angiomyxoma is a rare neoplasm that arise from soft tissue of the perineum and usually affects young woman. It has a high risk of local recurrence due to infiltrative lesion. This tumor should be distinguished from benign and malignant tumor or tumor like lesion of the perineum. We experienced a case of an aggressive angiomyxoma on soft tissue of the vaginal wall in 43-year-old woman and reported it with a brief review of literature.

타액선 종양의 방사선치료 (Radiotherapy for Malignant Salivary Gland Tumor)

  • 류성렬
    • 대한두경부종양학회지
    • /
    • 제9권1호
    • /
    • pp.98-101
    • /
    • 1993
  • Surgery has been known to be traditional treatment modality for the malignant salivary gland tumor, the tumors being considered as radioresistant. However, reviews of the literature have shown a high recurrence rate, especially in advanced and/or high grade tumors. The retrospective data suggests that conservative surgery with adjunctive radiation therapy is justified in view of the enhanced locoregional control. In inoperable and recurrent tumor, definitive radiotherapy can achieve $30{\sim}40%$ of average 5 year survival rate, but in early stage, local control and survival rate could be raised more than 80%. This results shown to be aggressive radiotherapy can replace surgical management for the selected cases of small sized tumor. Neutron therapy is another option for curative treatment of malignant salivary gland tumors.

  • PDF

하악골에서 발생한 골아 세포종을 닮은 골육종의 치험 1례 (Osteoblastoma-like Osteosarcoma occurred in the Mandible : Report of A Case)

  • 이성근;정인교;박혜련
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제22권3호
    • /
    • pp.364-368
    • /
    • 2000
  • Typical osteoblastoma is generally considered to be a rare benign primary bone tumor that is seen primarily in children and young adults and curable by complete excision. However, the recurrence, aggressive behavior, or malignant transformation of this lesion was reported in some cases. It is reported that the malignant or aggressive osteoblatoma is really osteoblastoma-like osteosarcoma. Therefore, although this lesion is diagnosed as benign histologically. the operator must observe the postoperative course carefully. This article is to report a case of osteoblastoma-like osteosarcoma occurred in the mandible of 22 years old male patient with literature review.

  • PDF

악성 혼합종의 임상적 고찰 (Malignant Mixed Tumor of Salivary Glands: A Clinical Study)

  • 오경균;이국행;이종호;심윤상
    • 대한두경부종양학회지
    • /
    • 제9권2호
    • /
    • pp.227-233
    • /
    • 1993
  • For malignant neoplasms of salivary tissues. two of the better determinants of progosis are histologic classification and size of the neoplasm. Proper management of these tumors requires an accurate diagnosis by the pathologist and correct interpretation by the surgeon. Malignant mixed tumors account for between 3 and 13 precent of all cancers of the salivary glands and 2 percent of all tumors in these locations. The typical history of these tumors is that of slowly growing mass demonstrating a sudden increase in growth. The duration of onset of the tumor mass and the diagnosis of malignancy has been demonstrated to be 10 to 18 years. The risk of malignat transformation of a benign mixed tumor increases with the duration of the tumor. We analyzed retrospectively 13 cases of malignant mixed tumor who visited from Jan. 1985 to Dec. 1992. Mean age of the patients was 56.5 years. The origin of tumors were parotid gland 7 cases, submandibular gland 2 cases, and minor salivary gland 4 cases(palate 3 cases, tonsil pillar 1 case). According to the criteria of the AJCC on staging, stage I was 1 case, stage II 1 case, stage III 2 cases, and stage IV 9 cases. Histopathologically, carcinma ex pleomorphic adenoma were 12 cases and the true malignant mixed tumor was 1 case. The major treatment modalities were curative surgery, and radiation therapy followed. In conclusion, aggressive therapy of combined surgery and postoperative radiation therapy is required for these lesions, and patients with known or suspected benign tumor should be encouraged to undergo surgery early on in their disease to avoid malignant degeneration at a later dete.

  • PDF

Intravascular papillary endothelial hyperplasia (Masson's hemangioma) of the face

  • Han, Jin Woo;Lee, Jong Hun;Kim, Eun Kyung
    • 대한두개안면성형외과학회지
    • /
    • 제20권2호
    • /
    • pp.109-111
    • /
    • 2019
  • Intravascular papillary endothelial hyperplasia or Masson's hemangioma is a rare vascular tumor. The reactive proliferation of endothelial cells in this disease mimics other benign or malignant vascular proliferation such as angiosarcoma or Kaposi's sarcoma. It is important to make an accurate distinction to avoid confusion with these malignant tumors. This would facilitate a proper diagnosis, which is essential so that the patient is not subjected to unnecessarily aggressive or inappropriate treatment.

상지에 발생한 악성 및 침윤성 종양의 분절절제 및 재접합술 (Segmental Resection and Replantation for Primary Malignant or Aggressive Tumors of the Upper Limb)

  • 한수봉;이우석;신규호
    • 대한골관절종양학회지
    • /
    • 제6권1호
    • /
    • pp.10-16
    • /
    • 2000
  • 목적 : 상지에 발생한 악성 및 침윤성 종양에서 분절절제 및 재접합술을 시행후 그 결과를 보고하고자 한다. 대상 및 방법 : 1986년부터 1994년까지 상지에 발생한 악성 및 침윤성 종양으로 분절절제 및 재접합술을 시행한 10례를 대상으로 평균 7년 7개월(3년 4개월~10년 2개월)간 추적하였다. 수술의 적응증은 절단 외에는 적절한 절제방법이 없는 stage II B의 종양을 대상으로 하였다. 종양의 종류는 연골육종이 3례, 골육종이 2례, 병적 골절을 동반한 거대세포종이 2례 동맥류성 골낭종을 동반한 광범위한 연골아세포종, 병적 골절을 동반한 광범위 유잉육종, 연부조직 및 골을 침범한 평활근육종이 각각 1례씩이었다. 종양의 발생부위는 근위 상완골이 6례로 가장 많았고 견갑골 3례, 전완부의 연부조직 1례였다. 10례중 7례에서 광범위 절제술을 시행하였고 3례에서는 변연절제술을 시행하였다. 결과 : 다발성 전이로 수술후 40개월에 사망한 1례를 제외하고 9례에서 종양의 국소재발이나 전이는 없었다. 최종추시시 상지의 평균기능점수는 65%(43~90%)였고, 수부의 파악력은 정상측에 비하여 평균 75%(28~95%), 집는 힘은 평균 82 %(63~100%)였다. 수술후 합병증으로는 3례에서 상처의 이개가 있었으나 치유되었고, 1례에서 수술후 요골신경의 마비소견이 보였으나 수술후 3개월에 신경기능은 회복되었다. 결론 : 상지에 발생한 악성 및 침윤성 종양의 치료로서 분절절제 및 재접합술은 선택적인 환자에서 절단술 대신에 부분 상지 구제술로서 추천할 수 있는 방법으로 사료된다.

  • PDF

원발성 종격동 종양 및 낭종의 임상적 고찰 (Clinical Review of Primary Tumors and Cysts of the Mediastinum)

  • 장기경
    • Journal of Chest Surgery
    • /
    • 제27권8호
    • /
    • pp.689-694
    • /
    • 1994
  • A retrospective analysis was performed on 36 patients with primary cysts and tumors of the mediastinum seen at the Department of Thoracic and Cardiovascular Surgery of Maryknoll Hospital from January 1983 to December 1993. There were 21 female and 15 male patients in the study. Ages ranges from 2 years to 72 years, with a mean of 34.7. There were 9 malignant tumors and 27 benign tumors.Thymic neoplasms were the most common. For the whole series, 29 of the patients had tumors in the anterior mediastinum. There appears to be an in6rease in tumors in the anterior compartment. There were 30 symptomatic patients in our series. Of the patients with malignant disease, 89 % were symptomatic. All of benign tumors were completely removed and malignant tumors were treated with chemotherapy and radiotherapy after operation. There were 9[27.3 %] postoperative complications. There was no postoperative mortality. Follow-up was available on 27 patients. There was no recurrence, malignant degeneration, or growth of any tumor. It is hoped that careful evaluation and aggressive treatment of mediastinal tumors will continue to provide improvement in the prognosis for these patients.

  • PDF

Soft tissue sarcoma in neurofibromatosis type 1: A rare case of malignant peripheral nerve sheath tumor of the skin

  • Chung, Young Hun;Jang, Jin Woo;Cho, Jae Young
    • Archives of Plastic Surgery
    • /
    • 제47권1호
    • /
    • pp.92-96
    • /
    • 2020
  • Malignant peripheral nerve sheath tumor (MPNST) is a rare and often aggressive soft tissue sarcoma originating from the sheaths of peripheral nerves. Approximately 50% of MPNSTs occur in patients with neurofibromatosis (NF). These tumors often present as deep soft tissue lesions, arising from the nerve plexuses of the extremities or from the nerves extending from the trunk. They rarely occur in the skin, especially in patients with NF. Herein, we report our experience with an MPNST of the skin in a patient with NF.

흉폐부에서 발생한 악성소세포 종양의 방사선치료 (Radiation Treatment for Malignant Small Cell Tumor of the Thoracopulmonary Region (Primitive Pluripotent Histogenesis and Differential Diagnosis - A Case Report and Review of Literatures -))

  • 오원용;양진영;황인순
    • Radiation Oncology Journal
    • /
    • 제9권1호
    • /
    • pp.117-122
    • /
    • 1991
  • 흉폐부 또는 흉벽에서 발생하는 악성소세포 종양군인 Ewings sarcoma, 횡문근육종, Askin tumor, 신경아세포종, PNET, 임파종 등은 현미경학적 소견만으로는 감별하기 어렵다. 그러나 최근에는 조직세포화학적검사, 면역세포화학적검사, 세포배양, 세포유전학적 검사등의 도움으로 상기한 악성소세포 종양군들이 모두가 같은 계통의 primitive pluripotent cells로 부터 분화되어 발병되는 것으로 확인되었다. 치료는 외과적 절제술, 방사선치료, 항암요법 등이 시도되고 있으나 예후는 재발 과원격전이로 인하여 불량한 것으로 보고되고 있다. 본 저자들은 본원에서 치료한 예를 보고하면서 흉폐부에서 발생하는 악성소세포 종양군의 조직발생과 감별진단에 대하여 논하고자 한다.

  • PDF